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Translation initiation factor eukaryotic translation initiation factor 4E (eIF4E) plays a key role in regulation
of cellular proliferation. Its effects on the m7GpppN mRNA cap are critical because overexpression of eIF4E
transforms cells, and eIF4E function is rate-limiting for G1 passage. Although we identified eIF4E as a c-Myc
target, little else is known about its transcriptional regulation. Previously, we described an element at position
25 (TTACCCCCCCTT) that was critical for eIF4E promoter function. Here we report that this sequence
(named 4EBE, for eIF4E basal element) functions as a basal promoter element that binds hnRNP K. The 4EBE
is sufficient to replace TATA sequences in a heterologous reporter construct. Interactions between 4EBE and
upstream activator sites are position, distance, and sequence dependent. Using DNA affinity chromatography,
we identified hnRNP K as a 4EBE-binding protein. Chromatin immunoprecipitation, siRNA interference, and
hnRNP K overexpression demonstrate that hnRNP K can regulate eIF4E mRNA. Moreover, hnRNP K
increased translation initiation, increased cell division, and promoted neoplastic transformation in an eIF4E-
dependent manner. hnRNP K binds the TATA-binding protein, explaining how the 4EBE might replace TATA
in the eIF4E promoter. hnRNP K is an unusually diverse regulator of multiple steps in growth regulation
because it also directly regulates c-myc transcription, mRNA export, splicing, and translation initiation.
eIF4E catalyzes the rate-limiting step in eukaryotic transla-
tion and was shown to be the least abundant of all translation
initiation factors in cells (27). Although it binds to the 5 cap
structures on all mRNAs, eIF4E must exert specific effects on
various mRNAs because it functions as an oncogene in trans-
formation assays (18, 52). Translational control by eIF4E spe-
cifically regulates steps in cell proliferation that are frequently
abnormal in malignant cells. For example, the yeast mutant
expressing a temperature-sensitive eIF4E (cdc33) arrests in G1
at its restrictive temperature (7).
eIF4E’s transforming function is likely to be clinically sig-
nificant because eIF4E is overexpressed in a variety of malig-
nant cells and tissues (15, 16, 53, 77). One critical role for
eIF4E in oncogenesis may be as the downstream effector of the
akt survival pathway that collaborates with various other on-
cogenes (83, 103). As such, it appears to work in part by
preventing apoptotic cell death (54). Whether its overexpres-
sion is a cause or an effect of malignant transformation remains
an intriguing and important question. In both head and neck
tumors, as well as in rare breast cancers, amplifications of the
eIF4E gene have been described (37, 92). However, noncyto-
genetic regulatory events appear to contribute to its overex-
pression in colon, lung, lymphoma, and bladder cancers (77).
The nature of these regulatory events remains unknown.
Despite the growing realization of its potential importance
in cancer, astonishingly little is known about mechanisms that
regulate levels of eIF4E (57). Numerous studies have shown its
functional regulation by various signal transduction pathways
and by binding to its antagonist, the 4E binding protein (re-
viewed in references 11 and 15). However, measurements of its
quantitative levels in cells have attracted much less attention
(101). Early studies that demonstrated serum and heat shock
regulation of initiation factors were hampered because eIF4E
levels were too low to detect in two-dimensional gels (24–26).
Tissue-specific changes in eIF4E mRNA have been demon-
strated in Drosophila and zebra fish (31, 39). In mammalian
systems, its levels vary during epithelial differentiation and
cardiocyte growth (56, 102). Our initial report that serum in-
duces eIF4E mRNA remains a critical demonstration that
transcriptional regulation of eIF4E can play an important role
in its overall regulation (80). Importantly, the promoter of the
eIF4E gene contains two essential E boxes that bind to, and
can be regulated by, the MYC oncogene (32, 46). However, an
additional site at25 in the promoter was equally important to
the function of the eIF4E promoter (45). Its position at 25,
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where TATA sequences would be anticipated, suggested that
eIF4E might be regulated by a unique basal promoter element.
To better understand the regulation of eIF4E in normal and
malignant tissues, we sought to further characterize this regu-
latory motif that we now designate the 4E basal element
(4EBE).
As in the case of eIF4E, little is known about transcriptional
regulation of other translation initiation factors. The abun-
dance of translation initiation factors eIF1 and eIF4A exceeds
the abundance of ribosomal proteins; both are therefore
among the most abundant proteins in the cell (26, 101). The
promoters for both follow the classic paradigm of strong pro-
moters that contain TATA sites (14, 73). The promoters for
eIF2 and eIF2 have also been analyzed in some detail.
eIF2 and eIF2 are both less abundant than ribosomal pro-
teins. Their promoters lack TATA sequences (9, 42), and they
both share a palindromic sequence (TGCGCATGCGCA) that
binds nuclear respiratory factor 1 (NRF-1). NRF-1 is thought
to coordinate transcriptional regulation of nucleus-encoded
respiratory proteins located in the mitochondria (9, 29, 47).
Also called -palindromic binding protein (-PAL), NRF-1
avidly binds the palindromic sequence in the eIF2 promoter
(8, 29). Overexpression of NRF-1 increases eIF2 and net
protein synthesis, although it actually inhibits cell division
through effects on E2F1 (30). Intriguingly, NRF-1 can het-
erodimerize with max, and the -PAL sequence is an alterna-
tive-binding site for Myc (4, 30, 80). Finally, an inhibitory
sequence in the first intron of eIF2 functions as an initiator
(INR) element, and INR elements are repressed by Myc (67,
81, 88).
Nuclear run-on experiments first demonstrated a connection
between Myc and transcription of translation initiation factors
eIF4E and eIF2 (80). Since then, accumulating data have
linked Myc regulation to ribosomal proteins and additional
translation initiation factors and thereby to growth regulation
in the cell (86). The c-Myc target gene database lists 16 trans-
lation initiation factors whose potential connections to Myc
regulation have been suggested (105). Evidence for this linkage
comes from chromatin immunoprecipitation, loss of expression
in c-myc-null cells, gain of expression in primary liver cells, and
increased expression resulting from conditional increases in
Myc function (32, 48, 68, 72). The best evidence for a Myc
connection is still found for eIF4E and eIF2, although the
rules associating Myc with regulation of these two factors re-
main ambiguous (105). Although Myc does not regulate these
factors in all circumstances, its regulation of translation initi-
ation is potentially important in cancer biology because a dom-
inant inhibitor of translation initiation blocks transformation
by Myc (55).
The location of the 4EBE at the site where TATA should be
found raises the possibility that it is a functional basal pro-
moter element. Two types of cis-acting DNA elements regulate
eukaryotic promoters transcribed by RNA polymerase II
genes: (i) basal or core promoter elements located near or at
the transcription initiation site and (ii) upstream or regulatory
promoter elements that are binding sites for various transcrip-
tion activators and/or repressors (40). Utilization of the
TATA-binding protein (TBP) is common to promoters tran-
scribed by all RNA polymerases (106). TBP is present in a
complex called TFIID containing TBP along with various TBP-
associated factors (TAFs) (28, 107, 108). Although TBP is
generally required for the transcription of most genes, the
identification of TBP-related factors TRF1 and TRF2 and a
TBP-free, TAF-containing complex, which lacks TBP but con-
tains TAFs, suggests that there are alternative mechanisms by
which transcription may be initiated in the case of certain
genes (34, 74). Additional basal promoter elements have been
identified that can be distinguished from TATA. Seminal work
contributed by Smale demonstrated an additional basal ele-
ment spanning the transcription initiation site that was called
the INR element that functions as a TATA equivalent in many
TATA-less genes (90). Initiator elements are especially impor-
tant in cell growth control since they were identified as the 
element in the promoters of ribosomal protein genes (1, 22, 35,
84). Specific DNA-binding proteins, including YY1, TFII-I,
USF, and E2F, bind initiator elements (2, 43, 44, 82).
In characterizing the eIF4E promoter, we identified protein
species of 68 and 97 kDa that bound the 4EBE (45). This
element, initially designated LS3 (5-TTACCCCCCCTT), is
highly conserved between mouse, rat, and human eIF4E pro-
moters (45, 56). We first considered that this element might be
a classic initiator because of its strategic location, the lack of a
TATA, and its pyrimidine richness. However, the element did
not cross-compete with known initiator sequences, was not
transactivated by YY1, and was not supershifted by antibodies
to any known initiator-binding proteins in electrophoretic mo-
bility shift assay (EMSA) experiments (45). Although C-rich it
also did not bind SP1 because SP1 oligonucleotides did not
cross-compete for binding and an antibody to SP1 did not
supershift complexes in EMSA experiments (45). Here we
examine the role of this element, which we now designate the
4EBE. We report that this sequence functions as a basal pro-
moter element in reporter gene experiments and binds the
transcription factor hnRNP K that is known to interact with
TBP (62). We go on to demonstrate that overexpression of
hnRNP K causes an eIF4E-dependent cellular transformation
that synergizes with Myc, identifying a new regulatory interac-
tion that could play a role in human malignancies overexpress-
ing eIF4E.
MATERIALS AND METHODS
Plasmids and plasmid construction. The E1bTATA CAT plasmid was used as
the starting plasmid for construction of reporter plasmids because it lacks any
known elements apart from its simple TATA. The sequence upstream of CAT in
this reporter is shown in Fig. 1 and specifically does not include the initiator
element from the E1b promoter. Initial constructs contained two Sp1 sites or
four E-box elements upstream of TATA or 4EBE where the E1bTATA was
replaced by 4EBE. The oligonucleotides used for all constructs are summarized
in Fig. 1. Briefly, double-stranded oligonucleotides with the appropriate over-
hangs containing two Sp1 binding sites or four E-box elements were synthesized
(Gibco-BRL) and annealed. In the cases where the E1bTATA was replaced by
4EBE, double-stranded oligonucleotides were synthesized containing the 4EBE
sequence with two Sp1 sites or four E-box elements upstream of 4EBE. Dia-
grams of the various plasmids are included in Fig. 2. The E1bTATACAT plasmid
was cut with the appropriate restriction enzymes and ligated with the double-
stranded oligonucleotides. (E-box)410 TATACAT was used as the template for
generating the plasmids (E-box)443 TATACAT, (E-box)4 10 4EBE CAT, and
(E-box)443 4EBE CAT.
For the constructs containing the linker scanning mutations in the eIF4E
promoter, the p4ECAT plasmid that contains 403 nucleotides of proximal pro-
moter sequence from the eIF4E genomic clone was used as the parental plasmid
(45). In order to generate mutations in the 4EBE site in the native 4E promoter,
the QuikChange site-directed mutagenesis kit was used (Stratagene). 5 and 3
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primers harboring the mutations in the middle of the primers were synthesized
and used for the generation of the mutations according to the manufacturer’s
instructions. The p4ECAT plasmid was used as the template. The various prim-
ers used for PCR-induced mutations are summarized in Fig. 1.
The expression plasmids pCEP4 (Invitrogen empty vector control [hygromycin
selectable]), pCEPmyc (human Myc driven by cytomegalovirus), and pCEP4EBP
(a constitutive dominant-inhibitory form of the 4E binding protein that blocks
eIF4E function) were described previously (55). pcDNA-hnRNP K was created
by using the cDNA for hnRNP K from an Image Clone purchased from Invitro-
gen that was then cloned into pcDNA3.1 (Invitrogen; G418 selectable) by using
NotI and XhoI restriction sites. An hnRNP K retroviral expression vector was
constructed by cloning the hnRNP K cDNA into the pBABE-puro vector by
using an EcoRI-XhoI fragment from pcDNA-hnRNP K.
Terminal oligopyrimidine (TOP) reporter plasmids, including rpL32-green
fluorescent protein (GFP) and a mutant rpL32-GH containing a C3A mutation
in its cap to eliminate TOP function were a generous gift from O. Meyuhas (96).
Cells, transfections, and chloramphenicol acetyltransferase (CAT) assays.
HeLa cells were obtained from the American Type Culture Collection, Manas-
sas, Va. Adherent cells were grown in Dulbecco modified Eagle medium sup-
plemented with 10% fetal bovine serum (FCS), antibiotics and L-glutamine.
HO15 (myc/) and TGR (myc/) cells were obtained from John Sedivy (59)
and were also grown in Dulbecco modified Eagle medium supplemented with
10% fetal bovine serum, antibiotics, and L-glutamine. Rat 1A cells were isolated
for their susceptibility to transformation in one step by Myc (93) and were
obtained from Chi Dang.
For CAT assays, exponentially growing HeLa cells were transfected in 100-mm
dishes by using standard calcium phosphate coprecipitations (85). Briefly, HeLa
cells were transfected with 10 g of CAT reporter plasmid and 2 g of pSVt-
FIG. 1. Oligonucleotides used in EMSA experiments.
6438 LYNCH ET AL. MOL. CELL. BIOL.
 o
n
 January 6, 2014 by W








khGH plasmid as internal control. Cells were fed with fresh medium 24 h after
transfection and harvested for CAT activity 48 h posttransfection by a standard
assay (46). The CAT activity in each case was normalized to human growth
hormone levels in the media, as determined by using a commercial radioimmu-
noassay kit (Nichols Institute) according to the manufacturer’s instructions.
Transfections were typically performed in duplicate and repeated three times.
Rat1A cells were transfected by using Lipofectin reagents (Gibco-BRL) with
pCEP4, pCEPmyc, and pCEP-4EBP, respectively, together with either
pcDNA3.1 or pcDNA-hnRNP K as indicated in individual figure legends. Pooled
transfectants were selected in the presence of 500 g of Geneticin and 200 g of
hygromycin/ml. Since all colonies expressed the transfected proteins due to the
double selection applied to all transfections, pooled transfectants were used in all
studies.
Packaged retroviruses expressing hnRNP K or a GFP control were made with
the EcoPac retroviral packaging vector; 293T cells were cotransfected with either
pBABE-GFP or pBABE-hnRNP K by using standard calcium chloride tech-
niques. Subconfluent HO15 cells were infected with 50% viral supernatants. Two
days after infection, puromycin was added at a concentration of 2 g/ml to select
for infected cells, and puromycin selection was continued throughout the re-
mainder of the experiment. After expansion, HO15 cells carrying either pBABE-
GFP or pBABE-hnRNP K were seeded in 35-mm plates and allowed to become
confluent. They were then serum starved for 48 h; half of the plates were
stimulated with 10% fetal bovine serum for 20 h. DNA synthesis was measured
by addition of [3H]thymidine (1 Ci of 50 mCi/mmol; MP Biomedicals) for the
last 2 h of serum stimulation and is plotted as the mean and standard deviation
for three determinations per condition. Cells were harvested by using a previ-
ously described method (75). Additional cells were expanded into 100-mm plates
for polysomal analysis by the method described below.
For hnRNP K siRNA experiments, proliferating TGR or HO15 cells were
transfected with 10 nM scrambled control duplex oligonucleotide (Dharmacon,
Inc.) containing sense 5-GCGCGCUUUGUAGGAUUCGtt-3 and antisense
5-CGAAUCCUACAAAGCGCGCtt-3. These transfections were compared to
10 nM small interfering RNA (siRNA) for hnRNP K (Hrpk_1 siRNA; Ambion,
Inc.) containing sense 5-GGAACAAGCCUUUAAAAGAtt-3 and antisense
FIG. 2. 4EBE can replace the TATA box in the E1b promoter. (A) The indicated promoter constructs were transfected into HeLa cells and
analyzed for CAT activity as described in Materials and Methods. The schematic diagram identifies pBLCAT3 (no element), E1bTATACAT
(TATA), and 4EBE CAT (4EBE). The CAT reporter activity is represented as the fold activation compared to CAT alone. All values are reported
as the mean increase  the standard error for three replicas in this and the subsequent panels. (B) The diagrammed activator/basal element
promoter constructs were transfected into HeLa cells and analyzed for CAT activity. Constructs are illustrated in the center and included plasmids
containing two Sp1 sites upstream of CAT or 10 bases upstream of TATA, 4EBE, or 4EBE  in the E1bCAT plasmid [(Sp1)2CAT, (Sp1)210
TATACAT, (Sp1)210 4EBE CAT, and (Sp1)210 4EBEmutCAT]. The CAT reporter activity is represented as the fold activation compared to the
CAT alone value taken from panel A. (C) Representative experiment showing the effect of distance between Sp1 and TATA or Sp1 and 4EBE
on transcriptional activity. Briefly, exponentially growing HeLa cells in 100-mm dishes were transiently transfected with 10 g of CAT reporter
plasmids containing two Sp1 sites 10 or 30 bases upstream of TATA or 4EBE [(Sp1)210 TATACAT, (Sp1)230TATACAT, (Sp1)210 4EBE CAT,
and (Sp1)230 4EBE CAT]. (D) Representative experiment showing the effect of distance between the E-box element and TATA compared to the
E-box element and 4EBE on transcriptional activity. Briefly, exponentially growing HeLa cells in 100 mm dishes were transiently transfected with
10 g of CAT reporter plasmids containing four E-box elements 10 or 43 bases upstream of TATA or 4EBE [(E-box)410 TATACAT, (E-box)443
TATACAT, (E-box)410 4EBECAT, and (E-box)443 4EBE CAT], along with 2 g of human growth hormone plasmid as an internal control.
Transfected cells were harvested 48 h posttransfection and assayed for CAT activity in all experiments.
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5-UCUUUUAAAGGCUUGUUCCtc-3. Transfections were accomplished by
using Oligofectamine (Invitrogen, Inc.) according to the manufacturer’s instruc-
tions. mRNA and protein were harvested after 48 h and analyzed for the ex-
pression of hnRNP K and eIF4E as described below.
Additional siRNAs were used to block eIF4E expression in Rat1A cells.
Proliferating Rat1A cells were transfected with 50 nM concentrations of the
following siRNA duplexes from Ambion, Inc.: siRNA ID 56229 E1 sense (GG
AUGGUAUUGAGCCUAUGtt), E1 antisense (CAUAGGCUCAAUACCAU
CCtt); and siRNA ID 56139 E2 sense (GGUGGGCACUCUGGUUUUUtt)
and E2 antisense (AAAAACCAGAGUGCCCACCtg). The cells were then
compared to a nontargeting siRNA duplex for luciferase containing the following
sequences (Dharmacon): nontargeting siRNA #2 sense, 5-UAAGGCUAUGA
AGAGAUACUU-3; nontargeting siRNA #2 antisense, 5-PGUAUCUCUUC
AUAGCCUUAUU-3.
These experiments were performed by using the same conditions as for the
hnRNP K experiments. Protein was harvested after 48 h and analyzed for eIF4E
and actin protein as described below. These siRNAs were then transfected into
Rat1A cells expressing hnRNP K and transferred into soft agar after 48 h. Soft
agar colony formation was evaluated 8 days later.
Protein purification and monitoring by Southwestern analysis. Nuclear ex-
tracts were prepared from at least 108 of HeLa cells growing in monolayer
culture by a modification of the Dignam method (19, 20, 65). The extraction
buffer was composed of 0.5% deoxycholate, 1% octyl--glucoside, 20 mM
HEPES (pH 7.9), 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM
phenylmethylsulfonyl fluoride (PMSF), 0.5 mM dithiothreitol (DTT), and 25%
glycerol. The initial crude extract was dialyzed overnight against hydrophobic
exchange column buffer [1 M (NH4)2SO4, 20 mM HEPES (pH 7.2), 100 mM
KCl, 0.2 mM EDTA, 0.5 mM PMSF, 0.5 mM DTT]. The precipitate resulting
from dialysis against the 1 M (NH4)2SO4 was removed by centrifugation at
14,000 rpm for 5 min in a microcentrifuge. The supernatant was loaded on a
phenyl Sepharose column and eluted by using a 1 to 0 M (NH4)2SO4 gradient
over 10 column volumes. Then, 1-ml fractions were collected and the positive
fractions were identified by using aliquots from the fractions in Southwestern
analyses as described below. The positive fractions were dialyzed overnight in
monoS column loading buffer (50 mM NaCl, 10 mM HEPES [pH 7.4], 5 mM
MgCl2, 1 mM EDTA, 1 mM DTT, 0.2 mM PMSF). The loading preparation was
cleared by centrifugation, and positive fractions were identified by Southwestern
analysis after elution from the monoS column with a 50 to 500 mM NaCl
gradient. The monoS-positive fractions were pooled and dialyzed overnight
against affinity binding buffer (50 mM NaCl, 5 mM MgCl2, 20 mM HEPES [pH
7.4], 1 mM DTT, 1 mM EDTA, 0.2 mM PMSF, 5% glycerol). Affinity binding to
a 1.2 mM concentration of a biotinylated 4EBE trimeric double-stranded oligo-
nucleotide (CTAGATTCCTCTTACCCCCCCTTCTTCCTCTTACCCCCCCT
TCTTCCTCTTACCCCCCCTTGG) was performed at 4°C for 20 min in the
presence of 0.4 g of salmon sperm DNA/l. Next, we added 100 l of strepta-
vidin beads, and binding continued for an additional 6 h at 4°C with gentle mixing
with continuous rotation. The streptavidin beads were then washed extensively
with the affinity binding buffer and spun gently, and the bound material was
eluted by boiling in standard Laemmli loading buffer. This preparation was run
on a 10% denaturing polyacrylamide gel, and a single protein band was identified
at 68 kDa by using colloidal blue staining.
Southwestern analyses were performed essentially as described previously (38,
89, 94, 100). Nuclear extracts (50 g) from the indicated cell types were run on
10% denaturing polyacrylamide gels, electroblotted to nitrocellulose for 12 h,
and allowed to dry. The filters were then immersed for 10 min in denaturation-
renaturation buffer containing 6 M guanidine hydrochloride. Partial renaturation
of immobilized proteins was effected by five successive incubations of the filters
in buffer containing progressive (twofold) dilutions of guanidine hydrochloride
and finally in buffer lacking the denaturant. Filters were blocked with 5% nonfat
dry milk in binding buffer (50 mM Tris [pH 7.5], 50 mM NaCl, 1 mM EDTA, 1
mM DTT) and were then washed twice with 0.25% nonfat dry milk in binding
buffer. Filters were hybridized in binding buffer containing Klenow-labeled LS3
trimer oligonucleotide probe, 0.25% nonfat dry milk, and 1 g of sonicated
salmon sperm DNA per ml for 60 min at room temperature. Filters were then
washed three times with binding buffer containing 0.25% nonfat dry milk alone
and dried.
Recombinant gst-hnRNP K was purified by using standard methods from
extracts of Escherichia coli transformed with pGEX-hnRNP K generously pro-
vided by David Levens (85, 98).
DNA-binding assays. HeLa nuclear extracts were obtained and analyzed by
using published methods (19, 97). Gel shift activity for 4EBE binding proteins
was determined in EMSA binding buffer (25 mM Tris [pH 7.5], 50 mM NaCl, 1
mM EDTA, 200 mM glycine, 0.1% Tween 20, 0.55 mg of bovine serum albumin/
ml, 10% glycerol) with 2 ng of poly(dI-dC)/l as a nonspecific competitor.
Complexes formed in binding buffer were resolved on a 4% nondenaturing
polyacrylamide gel containing 0.5	 TBE (0.045 M Tris-borate [pH 8.0], 0.5 mM
EDTA) at 4°C. After labeling with [
-32P]ATP with polynucleotide kinase, oli-
gonucleotides were purified by polyacrylamide gel electrophoresis. Each binding
reaction contained between 0.1 to 0.5 ng of labeled oligonucleotide. Competition
experiments were performed by using the indicated molar excess of unlabeled
oligonucleotides. Oligonucleotide sequences are provided in the relevant figures.
Chromatin immunoprecipitation assays. We evaluated TGR cells during log-
arithmic growth, at confluence after 72 h in the absence of serum to arrest the
cells, and 8 h after serum was added to the growth-arrested cells. Cells grown on
150-mm diameter plates were harvested and resuspended in growth medium.
Cross-linking was performed by adding fresh 37% formaldehyde to a final con-
centration of 1.5%, followed by incubation at room temperature for 15 min with
gentle agitation. The reaction was stopped by adding glycine to a final concen-
tration of 0.125 M, followed by incubation for 5 min. Cells were collected by
centrifugation at 1,500 	 g for 5 min; the pellet was washed twice with ice-cold
phosphate-buffered saline (120 mM NaCl, 2.7 mM KCl, 10 mM phosphate buffer
[pH 7.4]), washed twice with immunoprecipitation buffer (IP buffer; 150 mM
NaCl, 5 mM EDTA, 1% Triton X-100, 0.5% NP-40, 50 mM Tris-HCl [pH 7.5],
0.5 mM DTT), and then resuspended with IP buffer supplemented with 0.5%
sodium dodecyl sulfate (SDS) and protease inhibitor cocktail (Roche). Sonica-
tion was performed by Branson Sonifier 250 with a microtip at output 6 with 10-s
bursts until the desired DNA fragment sizes were reached. The lysate was then
subjected to centrifugation at 12,000 	 g for 10 min. The supernatant was
collected and diluted at least fivefold with IP buffer. For immunoprecipitation,
antibody was added to the lysate, followed by incubation at 4°C for 1 h with
agitation. Protein A-Sepharose beads (Amersham) were added to the mixture
and further incubated for 1 h. The beads were collected by centrifugation at 1,500
	 g for 30 s, washed twice with IP buffer, twice with high-salt IP buffer (500 mM
NaCl, 5 mM EDTA, 1% Triton X-100, 0.5% NP-40, 50 mM Tris-HCl [pH 7.5],
0.5 mM DTT), washed twice with stringent wash buffer (10 mM Tris-HCl [pH
7.5], 0.25 M LiCl, 0.5% NP-40, 0.5% sodium deoxycholate, 1 mM EDTA), and
washed twice with TE buffer (10 mM Tris-HCl, 0.1 mM EDTA). The bound
fraction was eluted by incubating the beads in elution buffer (TE with 1% SDS)
at 65°C for 10 min. The cross-links were reversed by incubating the eluate at 65°C
for at least 6 h. Samples were treated with proteinase K at 37°C for 1 h,
phenol-chloroform extracted, and ethanol precipitated. The following primer
sets were used in PCRs: pair 1, c-myc promoter (TACTCTACTCCAGCTCTG
GAACG, forward) and c-myc promoter (ACCTACGACAGATGAGGTCT
GAG, reverse); pair 2, nontranscribed locus AC120715 (ACCAGCCAGTCAG
AGTTCAGG, forward) and nontranscribed locus AC120715 (GGTTTCATCA
TCCCGAGAC, reverse); pair 3, eIF4E promoter (CTCCACTTCCCAGAAGC
CTCTTG, forward) and eIF4E promoter (CGGTTCCACAGTCGCCATCT
TAG, reverse); and pair 4, 5S rRNA genes (GTCTACGGCCATACCACCCT,
forward) and 5S rRNA genes (AAAGCCTACAGCACCCGGTA, reverse). Ali-
quots of the samples were assayed by PCR at 95°C for 30 s, 59°C for 45 s, and
72°C for 30 s for 35 cycles and then fractionated on an agarose gel.
Expression analyses for mRNA and protein. Levels of expression of myc,
hnRNP K, eIF4E, and actin mRNAs were analyzed by using total cellular RNA
from the indicated transfectants that was size fractionated (10 g/lane) on form-
aldehyde agarose gels, transferred to Hybond-N nylon matrices, and cross-linked
by using UV light (10). Filters were hybridized in a rapid hybridization solution
(Rapidhyb; Amersham) at 65°C with c-myc, hnRNP K, eIF4E, or actin cDNA
fragments 32-P labeled by the Klenow reaction by using random priming. For
Western analyses, cells were lysed in Laemmli loading buffer. A total of 10 g of
protein sample was subjected to SDS–10% polyacrylamide gel electrophoresis
and transferred to polyvinylidene difluoride membrane. Membranes were hy-
bridized with anti-hnRNP K (sc-25373; Santa Cruz), anti-eIF4E (BD610270;
Becton Dickinson), anti-Myc (SC41; Santa Cruz), or anti-actin (MAB1501R;
Calbiochem) as indicated and detected by enhanced chemiluminescence (Am-
ersham). For RNA blots of the polysomal and subpolysomal fractions, RNA was
extracted from the polysomal and subpolysomal fractions by using TRIzol re-
agent, and 50% of the harvested RNA was analyzed by using standard RNA
blotting techniques (85).
Polysomal profile analysis. One 100-mm diameter plate containing the indi-
cated stable Rat1A transfectants was harvested for each polysomal analysis.
Confluent transfectants were harvested and lysed in 300 l of RSB (10 mM NaCl,
10 mM Tris-HCl [pH 7.4], 15 mM MgCl2) containing 100 g of heparin/ml, 1.2%
Triton X-100, and 0.12% deoxycholate (60, 96). Nuclei were pelleted for 3 min
in a microcentrifuge at 4°C. The 300-l extract was layered over 11.5 ml of a 15
to 45% (wt/wt) sucrose gradient with a 0.5-ml cushion of 45% sucrose. The
gradients were centrifuged at 37,000 rpm for 2.5 h in an SW 41 (Beckman) rotor
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at 4°C. After centrifugation, the A260 was continuously monitored and recorded
across the gradient.
For the polysomal rpL32 transient reporter experiments, Rat 1A cells were
transfected in 100-mm plates with plasmids carrying either the 5-untranscribed
region of rpL32-GFP or the same untranscribed region lacking the consensus
5-terminal oligopyrimidine element designated rpL32(1CA)-GH. Trans-
fected cells were grown to confluence for 72 h, and during the last 24 h cells were
grown in medium lacking serum. For RNA blots of the polysomal and subpoly-
somal fractions, RNA was extracted from the polysomal and subpolysomal frac-
tions by using TRIzol reagent, and 50% of the harvested RNA was probed for
the GFP or GH cDNAs in the reporter genes by standard RNA blotting tech-
niques (49).
Cell characterization. Protein content per cell was determined by lysis of a
known number of cells in ELB lysis buffer and measurement of the protein
content of an aliquot of these lysates by using a kit from Bio-Rad.
Subconfluent transfectants were labeled with 10 M bromodeoxyuridine cell-
labeling reagent (Amersham Pharmacia) for 30 min and harvested for cell cycle
analysis. Cells were fixed in 80% ethanol for at least 1 h, incubated in anti-
bromodeoxyuridine antibody (Becton Dickinson) for 30 min and exposed to
anti-mouse-fluorescein secondary antibody (Vector Labs) for 30 min. Cells were
resuspended in propidium iodide (70 g/ml) supplemented with RNase A (25
g/ml) and analyzed. DNA content was measured by using a FACScan cytometer
(Becton Dickinson). The mean and standard error were determined for each cell
type in two repetitions of experiments with three independent assays per cell
type.
Clonogenicity of the Rat1A transfectants in soft agar was performed as de-
scribed previously (93). For the eIF4E siRNA experiments, Rat1A cells express-
ing hnRNP K were transfected with the nontargeting siRNA #2 from Dharma-
con, and the two siRNAs for eIF4E from Ambion; untransfected control Rat1A
cells expressing hnRNP K were included in the analysis of soft agar clone
formation. Transfection was allowed to proceed for 48 h when the cells were
treated with trypsin and replated in the soft agar. Colony numbers were scored
8 days later. For the pCEP4EBP experiments, cells were transfected for 48 h
and then placed in selection medium for an additional 48 h. They were then
transferred to soft agar and colonies were scored 14 days later.
RESULTS
4EBE can replace TATA in a heterologous promoter. We
previously reported that the eIF4E gene has a unique tran-
scription initiation site despite its lack of known basal pro-
moter elements (46). Using linker scanning mutants of the
eIF4E promoter to identify regions that were important for its
expression, we found a novel DNA element spanning positions
28 to 16, which we originally designated LS3 (5-TTACC
CCCCCTT), that was crucial for eIF4E expression (45). Due
to the strategic location of LS3 approximating that of TATA,
we first tested its function as a potential counterpart of a core
promoter element. We replaced the TATA-box in the
E1bCAT promoter with the element present in LS3 (here
renamed 4EBE) and tested it for transcriptional activity in
HeLa cells in transient-transfection assays. Placing 4EBE se-
quences upstream of the CAT reporter resulted in an increase
in transcriptional activity equivalent to that of the TATA alone
(Fig. 2A).
4EBE supports activated transcription. We next evaluated
the potential for 4EBE to support activated transcription by
placing two binding sites for the activator Sp1 about 10 bases
upstream of either TATA or 4EBE in the E1bCAT plasmid.
As shown in Fig. 2B, both TATA and 4EBE can mediate
Sp1-activated transcription, although TATA-mediated Sp1
transcription was stronger than 4EBE-mediated Sp1 transcrip-
tion. Mutating the 4EBE element (5-TTACCCCCCCTT to
5-TTTTTCCTTTTT) resulted in a dramatic decrease in tran-
scription activity similar to the absence of 4EBE or TATA.
These results demonstrated that 4EBE could mediate tran-
scriptional activity of the upstream activator Sp1 in transient-
transfection reporter gene assays. TATA appeared more effi-
cient in its ability to mediate activation by Sp1 when the
binding sites for Sp1 were placed in relatively close proximity
to TATA and was in general a stronger basal promoter ele-
ment than 4EBE at this distance.
Effect of spacing between TATA/4EBE and upstream acti-
vators on transcription. Gene expression is regulated by inter-
actions between the trans-acting factors that bind various cis-
acting DNA elements in the promoter of a gene. The spacing
of cis-acting elements in a promoter plays an important role in
determining the ability of the trans-acting factors to interact
with each other. In order to test the effect of spacing on the
interactions between 4EBE and various upstream activating
sequences, we placed two binding sites for Sp1 10 or 30 bases
upstream of the TATA or 4EBE in the E1bCAT plasmid and
four E-box elements 10 or 43 bases upstream of the E1bTATA
or 4EBE (Fig. 2D). As predicted, both E1bTATA and 4EBE
interacted best with Sp1 when Sp1 binding sites were close to
the TATA or 4EBE. Although the optimal spacing between
basal elements and E-boxes is not known, we chose 43 bases
because 4EBE is 43 nucleotides from the proximal E-box ele-
ment in the native eIF4E promoter. As shown in Fig. 2D, both
TATA and 4EBE mediated transactivation by E-box binding
proteins, but 4EBE was most active when separated from the
E-box by its native spacing interval.
The poly(C)-binding transcription factor hnRNP K binds to
the 4E-binding element. We purified proteins binding to the
4E-binding element by using a three-step purification proce-
dure that is described in the methods section and included a
DNA affinity step (Fig. 3). Purification was monitored by using
Southwestern analysis. As the first step, hydrophobic exchange
column chromatography through a 1 to 0 M (NH4)2SO4 gra-
dient provided a significant enrichment for the 68-kDa band
revealed by Southwestern analysis (Fig. 3A). As a second step,
either anion-exchange chromatography or cation-exchange
chromatography yielded very similar results (Fig. 3B) and
could be used interchangeably. A final DNA affinity step
yielded a single protein band at 68 kDa (Fig. 3C), which was
identified as the poly(C)-binding transcription factor by micro-
sequencing of the isolated protein band (Fig. 3D). hnRNP K
binds a C-rich CT element in the promoter of the c-myc gene
and has been shown to transactivate through binding to poly-
pyrimidine tract DNA elements (36, 62, 95, 98). We generated
a gst-hnRNP K fusion protein and found that this purified
hnRNP K binds 4EBE (Fig. 3E).
Nucleotides in 4EBE important for binding and transcrip-
tion. Known hnRNP K binding sites are remarkable for their
polypyrimidine tracks that follow a single purine (Fig. 4A). To
assess the similarity of the hnRNP K site to our 4EBE, two
nucleotides at a time were mutated in the 4EBE sequence
(5-CTCTTACCCCCCCTT), where the sequence indicated in
boldface was previously shown to be important for binding
activity and the 5 sequence CTC was shown to enhance bind-
ing in EMSAs (46) (sequences are presented in Fig. 4B). This
defined the nucleotides in the 4EBE sequence that are essen-
tial and sufficient for binding in EMSAs. As shown in Fig. 4C,
cold wild-type 4EBE oligonucleotide (lane 2) and cold oligo-
nucleotides for 4EBE mutants a, b, c, and g (lanes 3, 4,
5, and 9, respectively) were able to compete 4EBE in an
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EMSA, implying that these nucleotides were dispensable for
binding activity. The 4EBE mutant d partially competed
4EBE (lane 6). The 4EBE mutants e and f (lanes 7 and 8)
did not compete with the 4EBE oligonucleotide. Furthermore,
the 4EBE mutants that did not compete, 4EBE e and f, did
not show any binding activity in an EMSA when they were
themselves radiolabeled. 4EBE d did show partial binding
(lane 10), again correlating with partial competition with cold
d in lane 6. These data suggest that the nucleotides 4 to 9 in
the 4EBE sequence 5-TTACCCCCCCTT (shown in boldface)
are essential for binding in EMSAs. We further tested the
effect of the same mutations on transcriptional activity of
4EBE in transient-transfection assays. As shown in Fig. 4D the
4EBE mutants d, e, and f abrogated the transcriptional
activity of the native eIF4E promoter in reporter assays.
The myc CT element (CTE) is a six-mer repeat of a core CT
element (line B in Fig. 5A) (98). To further compare 4EBE
with the myc CTE, we performed competition experiments
between 4EBE probes and unlabeled myc-CT element com-
petitors in EMSAs (Fig. 5). A labeled 4EBE probe (oligonu-
cleotide A) was competed at equivalent concentrations of both
the cold myc CTE competitor (oligonucleotide B) and cold
4EBE itself (Fig. 5B, compare lanes 7 and 4). We then tested
competition with single-stranded versions of these oligonucle-
otides because hnRNP K binds single-stranded myc CTE se-
quences (6, 50, 97, 98). We again demonstrated equivalent
competition between the myc CTE and the 4EBE when both
were evaluated as single-stranded cold competitors (Fig. 5B,
compare lanes 13 and 10). Tomonaga and Levens further
showed that hnRNP K tightly binds dimers of the core myc CT
elements when separated by more than 12 nucleotides (oligo-
nucleotide D). We designed a matching dimeric oligonucleo-
FIG. 3. Purification of the 68-kDa protein binding to the 4EBE by DNA affinity chromatography identifies hnRNP K. (A) Hydrophobic
exchange chromatography was performed as the initial step in protein purification. Fractions identifying the 68-kDa species binding to the 4EBE
were identified by Southwestern analyses as described in Materials and Methods. Lane 1 contains a positive control HeLa nuclear extract (H), and
lane 2 contains an aliquot of the HeLa extract (L) before loading on the column. (B) The second step in purification used anion exchange
chromatography. Fractions identifying the 68-kDa species binding to the 4EBE were identified by Southwestern analyses as described in Materials
and Methods. The positive control HeLa extract was again included for comparison (H). (C) Two sequential bindings to a DNA affinity
chromatography matrix using a trimeric 4EBE sequence purified a 68-kDa band as demonstrated in this brilliant blue-stained acrylamide gel. Size
markers (M, lane 1), an aliquot of the positive fraction from the hydrophobic exchange column (A, lane 2), an aliquot of the positive fraction from
the monoS column (S, lane 3), and an aliquot of the DNA affinity wash (W, lane 5) are compared to the protein bound to the 4EBE-DNA affinity
matrix (D) shown in lane 4. (D) The 68-kDa protein band was submitted for sequencing and the indicated amino acid sequences were identified.
These correspond uniquely to hnRNP K. (E) Bacterially synthesized gst-hnRNP K was run in a standard Southwestern analysis, and the trimeric
4EBE probe bound to the gst-hnRNP K (H) but not to glutathione S-transferase alone (G). This band was confirmed to be hnRNP K by an
immunoblot analysis with anti-hnRNP K. Finally, the gel was also stained with brilliant blue to demonstrate loading of the species tested for binding
to the 4EBE.
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tide substituting the 4EBE sequence for the myc CTE (oligo-
nucleotide C). Using unlabeled versions of the dimeric 4EBE
and myc CTE as competitors, we again found equivalent cross
competitions to the labeled 4EBE probe (Fig. 5C, compare
lanes 7 and 4). We also tested these unlabeled competitors in
single-stranded forms and again found similar cross competi-
tion between the dimeric 4EBE and myc CTE (Fig. 5C, com-
pares lanes 13 and 10).
A rabbit polyclonal anti-C-terminal hnRNP K has been
shown to immunoprecipitate chromatin complexes containing
hnRNP K in inducibly transcribed loci (71). These experiments
confirmed the in vivo binding of hnRNP K to the actively
transcribed c-myc promoter. Using this same antibody we com-
pared the presence of hnRNP K at the eIF4E promoter to a
nontranscribed locus (GenBank accession number AC120715),
the 5S rRNA region and to the c-myc promoter (Fig. 6). Over-
all, this antibody specifically immunoprecipitated chromatin
containing the eIF4E promoter, indicating binding of hnRNP
K to the eIF4E gene in vivo. First, no signal was seen for
AC120715, eIF4E or c-myc in the arrested cells, and a non-
specific band was detected in all three immunoprecipitation
conditions for the 5S rRNA signal in these quiescent cells. In
the serum stimulated and growing cells the 5S rRNA and
nontranscribed locus bands were seen in equivalent and there-
fore nonspecific, amounts in the lanes containing nonimmune
rabbit serum, anti-hnRNP K antibody, or anti-hnRNP K with
a blocking peptide. In contrast, the c-myc and eIF4E PCR
signals were markedly higher in the anti-hnRNP K lanes than
in either the rabbit serum or blocking peptide control lanes
when cells were serum stimulated or actively growing. Com-
paring the absence of anti-hnRNP K eIF4E or c-myc chroma-
tin immunoprecipitation signals in the arrested cells to their
presence in the serum-stimulated and growing cells suggests
that hnRNP K is recruited to these loci in response to signals
regulating cell proliferation.
We transfected constructs expressing myc, hnRNP K, and
their combination into Rat 1A cells to evaluate the effect of
hnRNP K on eIF4E expression. Pooled transfectants express-
FIG. 4. Nucleotides in 4EBE sufficient and necessary for binding and transcription. (A) Diagram of 4EBE and comparison to promoter sites
known to interact with hnRNP K (76) (12, 21, 51, 87, 95). hnRNP K binding sites are highlighted in promoter sequences previously shown to be
regulated by hnRNP K. These are further compared to the 4EBE from human, rat, and mouse eIF4E promoters. (B) Schematic of mutations made
in 4EBE to evaluate the function of the polypyrimidine tract shared between the 4EBE and known hnRNP K binding sites. (C) Representative
EMSA depicting the nucleotides in 4EBE (5-CTCTTACCCCCCCTT) sufficient for binding. Radioactively labeled 4EBE oligonucleotide shows
two binding activities in an EMSA (lane 1 [arrows identify binding activity]). The binding to 4EBE is competed by adding 500-fold excess of cold
wild-type 4EBE oligonucleotide (lane 2) or 500-fold excess of cold 4EBE mutant oligonucleotides a, b, c, and g (lanes 3, 4, 5, and 9,
respectively). (D) Representative experiment correlating binding to 4EBE with transcriptional activity in transient-transfection assays in HeLa
cells. Briefly, mutations in the 4EBE sequence (d, e, and f) that did not show binding in EMSA were generated in the native 4E promoter,
as described in Materials and Methods. The CAT reporter plasmids for these mutants were subsequently transfected into exponentially growing
HeLa cells, along with the human growth hormone as an internal control for transfection efficiency. The cells were harvested 48 h posttransfection
and assayed for CAT activity as described in the text.
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ing exogenous myc, hnRNP K, and myc plus hnRNP K were
analyzed in Northern blots to demonstrate expression of the
introduced constructs (Fig. 7A) and evaluate their effect on
eIF4E mRNA. Both Myc and hnRNP K increased eIF4E
mRNA as predicted by their proposed interactions with its
promoter, and the two together produced a larger increase in
eIF4E than either alone. We then evaluated the ability of a
siRNA for hnRNP K to decrease eIF4E mRNA expression
(Fig. 7B and C). In myc wild-type (TGR  myc/) cells, our
siRNA successfully decreased hnRNP K protein levels com-
pared to scrambled oligonucleotide (Fig. 7B) and decreased
eIF4E mRNA levels. Since knockdown of hnRNP K could
have regulated eIF4E mRNA by indirect effects on Myc, which
is known to be responsive to hnRNP K (Fig. 7B), we also
evaluated the effect of the hnRNP K knockdown in myc-null
cells (Fig. 7C, HO15  myc/). Importantly, eIF4E mRNA
levels were decreased by the hnRNP K siRNA in both the myc
wild type and the myc-null cells.
Both hnRNP K and eIF4E transform cells (52, 58). To
address the potential significance of hnRNP K’s regulation of
eIF4E, we first compared the transforming potential of each
gene in Rat1A transfectants (Fig. 8). eIF4E protein levels in
Rat1A cells transfected with eIF4E (55) were very similar to
their levels in Rat1A cells transfected with hnRNP K (Fig. 8A).
We then found that hnRNP K transformed the target Rat1A
cells somewhat more potently than eIF4E, suggesting that it
has multiple effects on transformation in addition to any po-
tential effect mediated by eIF4E (Fig. 8B). eIF4E is known to
promote entry into S phase (18). To address hnRNP K’s effects
on cell cycle regulation, we therefore evaluated the ability of
hnRNP K to accelerate passage through G1 into S phase (Fig.
8C), as has been observed for eIF4E overexpression previously
(17, 18). As would be predicted if it regulates translation ini-
tiation through eIF4E, hnRNP K decreased the proportion of
cells in the G1 phase of the cell cycle and increased those in the
S phase. We also introduced hnRNP K into myc/ cells by
using a retroviral expression vector (Fig. 8D). In this case,
DNA synthesis was measured shortly after infection to exam-
FIG. 5. The endogenous binding activities to the 4EBE and the myc CTE are indistinguishable in EMSAs. (A) We compared DNA binding
to the eIF4E polypyrimidine element with binding to the myc CTE element first described as the DNA-binding site for hnRNP K (95). The
sequences of the DNA oligonucleotides tested in this experiment are labeled as A to D. We compared two configurations of the 4EBE (sequences
A and C) with identical configurations of the myc hnRNP K CTE binding site (sequences B and D). We compared a trimer of the eIF4E CT
element to a complete myc CT element of the identical length (sequences A and B, respectively). We further compared dimers of each individual
element separated by the myc CTE optimal distance (sequences C and D). The CT repeats in oligonucleotides A and B are highlighted by
underlining and overlining. The CT elements in oligonucleotides C and D are highlighted by underlining and italics. (B) EMSA findings with HeLa
whole-cell extracts bound to labeled oligonucleotide A. Binding was competed for by the indicated trimeric oligonucleotides A or B at the indicated
fold excess concentrations. Finally, we compared competition with double-stranded oligonucleotides (ds) or single-stranded oligonucleotides (ss).
(C) EMSA findings with HeLa whole-cell extracts bound to labeled oligonucleotide A. Binding was competed for by the indicated dimeric
oligonucleotides C or D at the indicated fold excess concentrations. We further compared competition with double-stranded oligonucleotides (ds)
or single-stranded oligonucleotides (ss).
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ine the acute effects of hnRNP K expression in the absence of
c-myc. We found significantly increased DNA synthesis in
hnRNP K-infected cells compared to a GFP-expressing vector
after serum stimulation (Fig. 8D).
Altering eIF4E levels should result in altered rates of trans-
lation initiation if hnRNP K’s regulation of eIF4E is biologi-
cally significant. To evaluate the effect of hnRNP K overex-
pression on global translation initiation rates, we compared the
net quantity of mRNAs contained in the actively translating
polysomal fractions of Rat 1A cells overexpressing hnRNP K
to those transfected with the vector alone (Fig. 9A). hnRNP K
produced a significant shift of the profile toward an increased
fraction of mRNAs in polysomes. Since hnRNP K could exert
this effect through regulation of c-myc, we further analyzed the
effects of hnRNP K expression in myc/ cells where we again
found that hnRNP K increased the proportion of mRNAs
present in actively translating, polysomal fractions of cellular
mRNAs (Fig. 9B). To evaluate hnRNP K’s effects on a single
mRNA that is known to be translationally regulated, we then
assessed the effect of hnRNP K on the translation rate of
ribosomal protein L32 (rpL32) in a standard translational re-
porter gene experiment (Fig. 9C). After transient transfection
of hnRNP K, a reporter gene under the translational control of
the 5 untranslated leader sequence of rpL32 shifted into the
polysomal fraction as expected. The 5 untranslated leader of
rpL32 contains a 5 terminal oligopyrimidine (TOP) sequence
as expected for a ribosomal protein. We were concerned that
the TOP sequence resembles an hnRNP K binding site and
that this shift might represent direct binding of hnRNP K to
the TOP reporter. We therefore also tested hnRNP K’s effects
on a mutated version of the rpL32 leader sequence that has
lost its TOP function and found that hnRNP K again had an
equal effect in enhancing its translation rate. Finally, we pre-
viously showed that loss of eIF4E function in cells transfected
with a dominant-inhibitory 4E binding protein (4EBP) results
in a paradoxical increase in cell size (55). This appears to be
related to disproportionate effects of eIF4E to enhance trans-
lation of mRNAs involved in cell division over those involved
in cell growth. We found no change in cell size in any of our
Rat 1A transfectants in response to hnRNP K. We therefore
evaluated the protein content per cell and found that hnRNP
K actually decreased protein content as predicted if it had
disproportionate effects on mRNAs that enhance cell division
over cell growth (Fig. 9D). A similar decrease in protein con-
tent per cell was observed for the cells overexpressing eIF4E
alone. Thus, although net translation initiation is enhanced by
hnRNP K, this effect may select for specific, cell cycle-promot-
ing mRNAs as we have observed with eIF4E.
Last, we sought to determine whether hnRNP K’s effects on
eIF4E were required for it to transform cells (Fig. 10). We first
tested two siRNA oligonucleotides that could block expression
of eIF4E protein in Rat1A cells (Fig. 10A). We transfected
these siRNAs into Rat1A cells overexpressing hnRNP K and
compared transformation efficiencies to the same cells that
were untransfected or were transfected with a control siRNA
for luciferase (Fig. 10B). As shown, the eIF4E siRNAs de-
creased formation of anchorage independent colonies by
Rat1A cells overexpressing hnRNP K.
We had previously developed a dominant inhibitory form of
the 4E binding protein (4EBP) that blocks eIF4E function,
which we designated 4EBP (55). In that study, 4EBP’s func-
tion was shown to depend on its interactions with eIF4E. We
had used that construct to show that eIF4E function was re-
quired for Myc transformation. We therefore applied the same
approach to confirming the importance of eIF4E function in
transformation by hnRNP K (Fig. 10C). We found that trans-
formation by hnRNP K depended on its effects on eIF4E
because cotransfection of a 4EBP that constitutively blocks
eIF4E function blocked soft agar transformation by hnRNP K
(Fig. 10C). The transforming efficiencies of eIF4E and hnRNP
K were more equivalent in this individual experiment than
FIG. 6. Chromatin immunoprecipitation demonstrates binding of
hnRNP K to the eIF4E promoter. Cell lysates from formaldehyde-
treated TGR cells in the indicated growth conditions were immuno-
precipitated with nonimmune rabbit serum (lane 2) or with anti-
hnRNP K antibody that was coincubated with (lane 4) or without (lane
3) the peptide used to generate the antibody in rabbits (99). DNA was
purified from the eluted complex and used as a template in PCRs with
primers to a nontranscribed rat locus (AC120715), the rat c-myc pro-
moter (c-myc), the eIF4E promoter (eIF4E), and the 5S rRNA region
(5S). PCR products were separated by agarose gel electrophoresis and
visualized with ethidium bromide. Input DNA was used as a positive
control in lane 1.
VOL. 25, 2005 hnRNP K IS AN eIF4E REGULATORY FACTOR 6445
 o
n
 January 6, 2014 by W








when data from four different experiments were evaluated in
Fig. 8B. Nevertheless, the 4EBP had a similar capacity to
block transformation by both eIF4E and hnRNP K overexpres-
sion.
DISCUSSION
Very little is known about the mechanisms underlying the
transcriptional regulation of eIF4E and other translation fac-
tors despite the fact that the levels of these translation factors
play an important role in cellular growth and differentiation
and in cancer. Ribosomal protein genes in yeast are regulated
as a function of cell growth by DNA factor(s) that are required
for activation and coordinated regulation of the whole family
of genes coding for the translational apparatus (41, 49). Much
less is known about the coordination of synthesis of the growth
apparatus of mammalian cells. We were therefore especially
interested in characterizing the second element in the eIF4E
promoter that was essential for its regulation (45).
We had previously demonstrated the required role of the
4EBE by using loss-of-function studies. We therefore evalu-
ated its potential function as a dominant expression element by
comparing it to TATA sequences that it appears to replace.
This is especially important because basal promoter elements
determine the range of transcriptional activators that regulate
individual promoters (13). The regulation of eIF4E levels in
the cell represents a particular physiologic challenge because
the range of normal expression levels of eIF4E is very narrow.
With the exception of mRNAs that use internal ribosomal
entry sites, eIF4E is required for translation initiation of nearly
all mRNAs. It must therefore be expressed ubiquitously in all
cells at some undefined minimum level. In contrast, as little as
a threefold increase in eIF4E levels is sufficient to derepress
translation of at least a subset of mRNAs that can transform
cells to a malignant phenotype (7, 91).
Using standard reporter gene analyses we show here that the
4EBE can function like TATA to drive reporter gene expres-
sion, and its activity can be enhanced by either SP1 or E-box
FIG. 7. Overexpression of hnRNP K and hnRNP K knockdowns regulate endogenous eIF4E mRNA. (A) Rat 1A cells were transfected with
vector alone, myc, hnRNP K, or the combination of hnRNP K and myc. Pooled transfectants were selected in neomycin and hygromycin and grown
to confluence. mRNA was harvested, and 5 g was run in a Northern analysis. The same blot was probed for the indicated genes, including c-myc,
hnRNP K, eIF4E, and actin. The probes used for the c-myc and hnRNP K blots were the human full-length cDNAs used to construct the expression
vectors to increase the specificity of detection of the transfected sequences. The actin and eIF4E probes were mouse full-length cDNA probes. (B
and C) TGR (myc/) (B) and HO15 (myc/) (C) cells were transiently transfected with an siRNA oligonucleotide for hnRNP K. Expression
of hnRNP K protein and eIF4E mRNA were analyzed 48 h after transfection in confluent transfected cells. Loading controls include actin protein
and the rRNA bands on an ethidium bromide-stained gel. The levels of hnRNP K protein, myc protein, and eIF4E mRNA were compared in cells
transfected with an siRNA for hnRNP K (si) to those transfected with a scrambled siRNA (sc).
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elements (Fig. 2). Our reporter experiments do not eliminate
the possibility that the 4EBE might also be functioning to bind
a classic transcriptional activator. Further in vitro studies will
be required to prove this point, but our reporter gene studies
make 4EBE an interesting candidate to be an additional basal
control element (40). The simple structure of the eIF4E pro-
moter now includes a required E-box element and a promoter
element that appears to replace TATA. To better understand
this simple form of regulation, we then sought to identify the
factor(s) that might bind to the 4EBE.
We identified hnRNP K as a candidate 4EBE binding pro-
tein by using standard protein purification methodology.
Known interactions of hnRNP K with other promoters, espe-
cially c-myc, make it an especially interesting candidate eIF4E
regulatory factor. eIF4E is a candidate myc target gene (86),
and hnRNP K is one of the most important transcriptional
controls of the c-myc promoter (36, 62, 95, 98). The coinci-
dence of hnRNP K regulation of both myc and eIF4E promot-
ers, together with the candidate role of myc in regulating
eIF4E, would suggest that complex combinatorial interactions
between myc and hnRNP K could be especially important in
controlling eIF4E levels. Indeed, we initially showed that the
eIF4E regulatory factor increases in cells in direct relationship
to myc levels, as might be expected if this factor can regulate
myc or is regulated by myc (45). Michelotti et al.’s demonstra-
tion that hnRNP K directly interacts with the TBP (62) fits our
FIG. 8. Overexpression of hnRNP K transforms cells and enhances passage through G1. (A) eIF4E protein levels were compared between
Rat1A cells transfected with hnRNP K and cells transfected with an expression construct for eIF4E (55). Vector control transfected cells (C1) for
the hnRNP K transfectants, the hnRNP K transfectants (HN), vector control transfected cells for the eIF4E transfectants (C2), and the eIF4E
transfectants (4E) are shown. Immunoblots for eIF4E and actin are shown. (B) The cells presented in panel A were then evaluated for
transformation in a standard soft agar assay. Plotted is the mean and standard error of the fold change in cells per well for six wells each in four
separate repetitions of the experiment comparing transfected constructs to vector control cells for each repetition (n  24 for each plot). The
hnRNP K and eIF4E transfectants are indicated. (C) Rat1A cells transfected with the indicated constructs were analyzed by fluorescence-activated
cell sorting for DNA content. Plotted is the percentage of cells in the G1, S, and G2 phases for three separate determinations for each of the two
times the experiment was repeated, together with the standard error of the mean for these determinations. Cells studied were transfected with the
indicated expression vectors, including the vector control (vec), myc, and hnRNP K. These determinations were made for actively proliferating
subconfluent cells. (D) Myc/ cells were infected with retroviruses expressing either GFP or hnRNP K. The infected cells were grown to
confluence and were then growth arrested over 48 h by removing serum from the culture medium. DNA synthesis was measured as described in
Materials and Methods in the subsequent absence (arrested) or presence (stimulated) of serum for 20 h. hnRNP K infection alone did not enhance
DNA synthesis in the growth arrested cells but significantly increased DNA synthesis after cells were stimulated to initiate division.
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demonstration that the 4EBE is a core promoter element in
the eIF4E promoter. Using EMSAs, additional reporter gene
experiments and chromatin immunoprecipitation we demon-
strated that the polypyrimidine track in the 4EBE functioned
like that in the myc promoter and that both elements func-
tioned identically as DNA-binding elements (Fig. 4 to 6).
We then transfected hnRNP K singly and together with Myc
to assess the functional significance of hnRNP K as a 4E
regulatory factor (Fig. 7). eIF4E mRNA levels increased in
response to hnRNP K in pooled, selected transfectants over-
expressing hnRNP K. Moreover, this increase was further aug-
mented if both myc and hnRNP K were transfected into the
cells. We then identified a siRNA that could knock down
hnRNP K protein levels. In siRNA knockdown experiments we
used TGR cells that are an immortalized diploid rat cell line so
that we might also evaluate hnRNP K loss in the corresponding
myc-null isolate (HO15) (59). Transient transfection of an
hnRNP K siRNA markedly inhibited hnRNP K protein levels
and decreased eIF4E mRNA levels 48 h after transfection. The
loss of eIF4E expression in response to loss of hnRNP K might
FIG. 9. Overexpression of hnRNP K alters translation rates. (A) Polysomal profiles of Rat 1A cells transfected with hnRNP K (dark black line)
were compared those containing an empty vector control (gray line). Cells were grown to confluence for 48 h in medium lacking serum, and
cytoplasmic extracts were run on standard sucrose gradients to separate mRNAs in monosomal versus polysomal fractions. The y axis identifies
UV absorption in relative units, and the x axis identifies fractions of the gradient in relative time from least dense on the left to most dense on
the right. (B) Polysomal profiles of myc/ cells infected with pBABE-hnRNP K (dark black line) were compared to those infected with
pBABE-GFP (lighter gray line). Cells were again evaluated at confluence in the absence of serum stimulation. Axes are as described in panel A.
We further indicate the mean and standard error of the percentage of RNAs found in the subpolysomal versus polysomal fractions for two replicas
for each analysis. (C) To confirm the global patterns of polysomal fractionation, we then analyzed the fractionation of reporter genes coupled to
the translationally regulated leader sequence of ribosomal protein L32. We compared a reporter construct containing the 5TOP from ribosomal
protein L32 (rpL32) coupled to a GFP cDNA with a reporter construct containing the inactivated TOP sequence from rpL32 coupled to a growth
hormone cDNA. These two constructs were transfected into Rat1A cells in the absence or presence of pcDNA-hnRNP K. The cells were grown
to confluence over 72 h and serum was withdrawn for the last 48 h before harvest. Polysomal (P) and subpolysomal (S) pooled fractions were
isolated by using sucrose density gradients. The mRNAs contained in each pool were isolated from the cells transfected either with (hnRNP K)
or without (pcDNA) the hnRNP K expression vector. The pooled polysomal and subpolysomal RNAs were then blotted in standard RNA blots
and probed for the GFP (rpl32) and growth hormone (rpl32) reporters. The ratio of the intensity of the signal in the polysomal fraction
(P) compared to the subpolysomal fraction (S) demonstrates increased translation initiation rates. (D) Subconfluent, proliferating Rat 1A cells
from Fig. 7 transfected with eIF4E and hnRNP K were harvested, and the protein content per cell was measured for each construct.
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be an indirect effect of the parallel myc knockdown in myc
wild-type cells since hnRNP K is known to regulate c-myc. We
therefore repeated these experiments in myc-null cells. The
hnRNP K knockdown had less effect on eIF4E mRNA levels in
the myc-null cells, either due to a change from myc depen-
dence in the TGR cells where the siRNA also affected eIF4E
regulation by c-myc or because they are slower growing and
therefore harder to optimally transfect. Nevertheless, we again
saw decreases in eIF4E mRNA 48 h after introduction of the
hnRNP K siRNA.
We have previously shown that eIF4E leads to preferential
effects on mRNAs that regulate cell division over those that
regulate cell growth as one potential explanation for its ability
to transform cells (78, 79). This appears to be a mechanism
through which cell growth can be coordinated with cell divi-
sion. We would predict that an eIF4E regulatory factor should
phenocopy some effects of eIF4E itself. We therefore first
compared transformation by eIF4E to hnRNP K and found
that hnRNP K was a somewhat more potent transforming
agent at similar levels of eIF4E (Fig. 8A and B). hnRNP K
overexpression also caused the same kinds of changes in cell
proliferation patterns as those seen for eIF4E because its over-
expression led to a decreased proportion of cells in the G1
phase of the cell cycle and accelerated entry into S phase (Fig.
8C and D).
hnRNP K is a multifunctional protein known to translation-
ally repress several mRNAs (5), especially those involved in
erythrocyte differentiation (33, 69). For example, the DICE
element in the 15-lipoxygenase mRNA is silenced by hnRNP K
in actively proliferating erythroid precursors. Our findings sug-
gest that, in contrast, hnRNP K should actually enhance trans-
lation initiation through increased eIF4E. To resolve these
apparent differences, we analyzed global translation initiation
rates in hnRNP K-overexpressing cells by using polysomal pro-
files. We compared the amounts of mRNA in polysomal versus
nontranslating fractions in Rat 1A and myc/ cells expressing
increased amounts of hnRNP K to control cells (Fig. 9A and
B). hnRNP K expression caused a clear shift toward increased
mRNAs in the polysomal fraction that is actively translating
mRNA. We also assessed the effect of hnRNP K on a 5TOP
reporter construct (Fig. 9C), which also showed enhanced
translation initiation through a generalized enhancement of
translation initiation. Thus, hnRNP K globally stimulates
translation initiation, as one would expect of a factor that
regulates eIF4E. Its repression of the DICE element is likely
therefore a narrower function unique to that mRNA. We have
shown that loss of eIF4E function has more effect on mRNAs
regulating cell division than cell growth by effects on cell size
and protein content (55). We therefore compared the cellular
protein content of cells overexpressing either hnRNP K or
eIF4E and found similar effects on cellular protein content;
our findings were again consistent with the idea that both of
them enhance expression of mRNAs involved in cell division in
preference to those controlling cell growth (Fig. 9D).
Finally, we assessed the significance of eIF4E regulation by
hnRNP K as a potential contributor to eIF4E’s role in malig-
nancy. Averaged over four experiments, hnRNP K more effi-
ciently transformed cells than equivalent amounts of eIF4E
expressed on its own (Fig. 8B). However, blocking eIF4E ac-
tivity blocked transformation by hnRNP K by using two differ-
ent methods to inhibit eIF4E (Fig. 10). Thus, although eIF4E
is certainly not the only target of hnRNP K that functions in its
ability to transform cells, it is an important one.
Taken together, our data strongly suggest that hnRNP K is
a likely candidate eIF4E regulatory factor (4ERF). Purification
FIG. 10. hnRNP K transforms cells through effects on eIF4E ex-
pression. (A) Rat1A cells were transfected with a control RNA (CR)
and two siRNAs for eIF4E (E1 and E2) as described in Materials and
Methods. Protein extracts were made 48 h after transfection and eval-
uated for eIF4E and actin levels by immunoblotting. An untransfected
control lane is also included (lane C). (B) Rat1A cells expressing
hnRNP K from Fig. 7 above were transfected with the control siRNA
and the two siRNAs from panel A. Additional hnRNP K-expressing
cells were examined without transfecting them (control). At 48 h after
transfection the cells were seeded for a soft agar assay. The mean and
standard error of colonies per well, evaluated 8 days after the cells
were put in soft agar for each condition, were plotted. (C) Rat1A
transfectants were evaluated for transformation in a standard soft agar
assay. Shown are cells transfected with a vector control, a dominant
inhibitor of eIF4E function (4EBP), hnRNP K, eIF4E, the combina-
tion of the dominant inhibitor of eIF4E, together with hnRNP K, and
the combination of eIF4E, together with the dominant inhibitor of
eIF4E, as indicated in the figure. Plotted is the mean and standard
deviation of the cells per well for four wells each in two separate
repeats of the experiment.
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of hnRNP K by 4EBE binding, demonstration of in vitro-
synthesized hnRNP K binding to the 4EBE, demonstration
that 4EBE binding is identical to myc CTE binding, regulation
of endogenous eIF4E levels by altering hnRNP K levels, and
similar cellular behavior of cells overexpressing hnRNP K and
eIF4E are all most consistent with this view.
hnRNP K is more abundant than most typical transcription
factors, and it affects nearly every step in transcription and
translation (5). Moreover, it is an unusual transcription factor
since it also binds to single-stranded DNA (ssDNA) and single-
stranded RNA. Its functions as a candidate transcription factor
need to be interpreted in this light. Its binding to TBP is
consistent with our proposal that it could act to recruit TBP to
the 25 region of the eIF4E promoter. In this view, the 4EBE
likely functions as the equivalent of a basal promoter element.
In contrast, the presence of a transactivation domain in the
hnRNP K N terminus is more consistent with the view that
hnRNP K might be acting as another activating protein, al-
though the transactivation domain in hnRNP K is relatively
weak (62, 98). Perhaps the most intriguing possibility is that
hnRNP K acts indirectly to promote melting of promoter re-
gions by virtue of its preferential binding to ssDNA (97). In this
FIG. 11. Polypyrimidine elements in mammalian translation initiation factor promoters. The genomic sequences of thirty-eight human
translation initiation factor genes (eIFs) were identified by using LocusLink (104). Five thousand nucleotides 5 to and 3 to the transcription
initiation site of each gene were downloaded into Clone Manager Suite 7 for further manipulation (Scientific and Educational Software, Durham,
N.C.). The immediate promoter regions of all of these sequences were inspected for sequences containing stretches of eight or more pyrimidines
that were less than 20 nucleotides from the transcription initiation site or the translation initiation codon. Thirteen human eIFs revealed such
sequences. Two thousand nucleotides surrounding the transcription initiation site of the 13 candidates were then used in a BLAST search of the
mouse and rat genomes. Promoter regions were considered to be confirmed if this region showed 70% homology, and it fell within a calculated
CpG island in all three species. The polypyrimidine stretches were conserved between mouse, rat, and human genomes in nine of the confirmed
promoter candidates as shown. Listed are the 70 nucleotides containing the proximal promoter sequences from all three species for the nine
candidates containing conserved polypyrimidine stretches, and the polypyrimidine stretches are identified by gray highlighting. The transcription
initiation sites identified in the genome databases were confirmed or modified by a BLAST comparison of each genomic sequence against available
expressed sequence tag sequences for each species. Indicated as white letters against a black background are either the site listed in LocusLink
as the transcription initiation site, the site mapping of the 5 end of the majority of all of the available ests for the indicated species, or the 5-most
expressed sequence tag sequence if no consensus 5 end was obvious. The translation initiation codon (ATG) is identified for the eight candidates
where it is positioned close to the transcription initiation site. Myc binding sites (CACGTG) were identified by locating Pm1I sites in each promoter
and are shown in boldface, underlined italics with gray highlighting. Remarkably, Myc binding sites were located at extremely short distances from
the initiation site of seven of the nine candidate promoters; four were within 50 nucleotides, two were at about 150 nucleotides, and one was about
500 nucleotides distant. A nuclear respiratory factor 1 palindromic sequence (NRF-1 PAL) binding site that also binds max and may be an
alternative Myc binding site is identified in the eIF2S2 promoters. LocusLink identifications include eIF2S2 (human 8894, mouse 67204, and rat
296302), eIF2S3 (1968, 26905, and 299027), eIF3S1 (8669, 78655, and 311371), eIF3S3 (8667, 68135, and 299899), eIF3S5 (8665, 66085, and
293427), eIF3S6 (3646, 16341, and 299872), eIF3S10 (8661, 75705, and 300253), eIF4B (1975, 75705, and 300253), and eIF4E (1977, 13684, and
117045). The eIF3S1 mouse promoter sequences are assumed based on their homology to the rat and human sequences. We found no mouse
cDNA or EST sequence that matched this sequence, and it was not annotated as the promoter sequence in the genome database.
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view, hnRNP K acts as a structural activating protein that
regulates DNA conformation to promote transcription (6).
Such ssDNA binding properties would allow hnRNP K to act
on its own without requiring interactions with other parts of
the transcription apparatus. ssDNA binding proteins are
known to relieve the torsional stress of transcription and so
enhance the rate of transcription by this alternative mechanism
(50). Although we observed ssDNA binding by hnRNP K to
the 4EBE in the eIF4E promoter, it was not as strong as was
described for the myc CT-element by the Levens group. Clar-
ification of the relative importance of these three mechanisms
to hnRNP K’s regulation of eIF4E will require additional ex-
ploration of all three mechanisms. Other proteins are also
known to bind similar single-stranded polypyrimidine tracks,
including several that bind to polypyrimidine elements in the
c-myc promoter, and most function both as transactivators and
to regulate DNA conformation (64). Any of these additional
proteins are potential additional or alternative eIF4E regula-
tory factor candidates that will require additional future as-
sessments. These proteins include the far upstream sequence
binding protein (23), the Pur proteins (3, 87), the cellular
nucleic acid binding protein (63), and myc single-stranded pro-
teins (66). Finally, the nature of the 97-kDa protein that we
originally identified remains unknown from these initial puri-
fication studies (45).
Overexpression of hnRNP K produced changes in global
translation initiation rates, suggesting the possibility that the
polypyrimidine sequence in the eIF4E promoter might be a
unifying regulatory motif for additional translation initiation
factors. This would be a particularly interesting result, given
how little we understand mechanisms by which translation
initiation factor synthesis might be coordinated. To evaluate
this possibility, we inspected the proximal promoter regions of
all 38 human translation initiation factors and found that eight
additional promoters contained polypyrimidine stretches anal-
ogous to the sequence in eIF4E (Fig. 11). All nine polypyri-
midine stretches were conserved in human, mouse, and rat
genomes. All fell within 20 nucleotides of either the transcrip-
tion initiation site or the translation initiation codon. More-
over, the location of c-Myc binding sequences within 10 to 500
bp of these polypyrimidine stretches in nearly all of these same
promoters suggests that the E-box–polypyrimidine combina-
tion in the eIF4E promoter could be a regulatory motif that
might regulate additional translation initiation factors.
Identification of hnRNP K as the leading 4ERF candidate
suggests a variety of additional directions for further study. Its
role in human cancers merits further clinical studies to see
whether abnormalities in hnRNP K expression, distribution, or
signaling function coincide with overexpression of eIF4E (70).
The nature of its interactions with Myc will need further elu-
cidation to determine whether it interacts with the regulation
of other genes transactivated by Myc. The coincidence of c-
Myc binding sites and polypyrimidine stretches in additional
translation initiation factors makes this a particularly impor-
tant issue. Why hnRNP K might play such a prominent role in
eIF4E regulation or global regulation of translation initiation
is equally interesting. hnRNP K is downstream of multiple
signal transduction pathways where integration between sig-
naling cascades and net translation capacity of the cell might
provide a significant evolutionary advantage (5). Moreover,
hnRNP K has a unique KNS-mediated nuclear importation
signal that is dependent on RNA polymerase II transcription
(61). This dependence of hnRNP K nuclear localization on
polymerase II activity might provide a mechanism to adjust
eIF4E and other translation initiation factors to net mRNA
copy numbers in the cell. Regardless, the identification of
hnRNP K as a 4ERF will certainly guide further explorations
of mechanisms that govern eIF4E levels in the cell.
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